Kewaunee Scientific Corp (KEQU) is a publicly traded Consumer Cyclical sector company. As of May 21, 2026, KEQU trades at $40.47 with a market cap of $109.87M and a P/E ratio of 10.16. KEQU moved +0.00% today. Year to date, KEQU is +10.13%; over the trailing twelve months it is +10.99%. Its 52-week range spans $30.33 to $71.33. Rallies surfaces KEQU's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What changed in KEQU news today?
Kewaunee Scientific Q3 Sales Up 3.3% to $69.4M, Pre-Tax Earnings Jump 25.8%: Kewaunee Scientific’s Q3 sales rose 3.3% to $69.4 million, while pre-tax earnings increased 25.8% to $1.6 million despite net earnings falling to $0.7 million. Order backlog declined to $183.2 million while domestic sales dipped 2.0% and international revenue jumped 21.4%.
HULL THOMAS DAVID III sold 2.18K (~$81.64K) on Jan 7, 2026.
Gardner Donald T. III sold 2.00K (~$75.14K) on Jan 6, 2026.
HULL THOMAS DAVID III sold 629 (~$23.69K) on Dec 31, 2025.
KEQU Analyst Consensus
KEQU analyst coverage data. Average price target: $0.00.
Common questions about KEQU
What changed in KEQU news today?
Kewaunee Scientific Q3 Sales Up 3.3% to $69.4M, Pre-Tax Earnings Jump 25.8%: Kewaunee Scientific’s Q3 sales rose 3.3% to $69.4 million, while pre-tax earnings increased 25.8% to $1.6 million despite net earnings falling to $0.7 million. Order backlog declined to $183.2 million while domestic sales dipped 2.0% and international revenue jumped 21.4%.
Does Rallies summarize KEQU news?
Yes. Rallies summarizes KEQU news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is KEQU research on Rallies investment advice?
No. Rallies provides research, data, and educational context for KEQU. It does not provide personalized investment advice.
